27
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden

ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 493-506 | Received 06 Feb 2024, Accepted 18 May 2024, Published online: 09 Jun 2024

Figures & data

Table 1 Number of Packs Used for Each SCIT Regime

Figure 1 Summary of cost contributions for SCIT and SLIT regimes across both cohorts.

Abbreviations: SCIT, subcutaneous immunotherapy; SEK, Swedish Krona; SLIT, sublingual immunotherapy.
Figure 1 Summary of cost contributions for SCIT and SLIT regimes across both cohorts.

Figure 2 Mean total annual appointment costs (A) with payer breakdowns (B).

Abbreviations: SCIT, subcutaneous immunotherapy; SEK, Swedish Krona; SLIT, sublingual immunotherapy.
Figure 2 Mean total annual appointment costs (A) with payer breakdowns (B).

Figure 3 Mean total annual medication costs (A) with payer breakdowns (B).

Abbreviations: AR, allergic rhinitis; SCIT, subcutaneous immunotherapy; SEK, Swedish Krona; SLIT, sublingual immunotherapy.
Figure 3 Mean total annual medication costs (A) with payer breakdowns (B).

Figure 4 Mean total annual private transport costs (A) with transport mode breakdowns (B).

Abbreviations: SCIT, subcutaneous immunotherapy; SEK, Swedish Krona; SLIT, sublingual immunotherapy.
Figure 4 Mean total annual private transport costs (A) with transport mode breakdowns (B).

Figure 5 Mean total annual travel absenteeism costs (A) with transport mode breakdowns (B).

Abbreviations: SCIT, subcutaneous immunotherapy; SEK, Swedish Krona; SLIT, sublingual immunotherapy.
Figure 5 Mean total annual travel absenteeism costs (A) with transport mode breakdowns (B).

Figure 6 Mean total annual waiting time-related absenteeism.

Abbreviations: SCIT, subcutaneous immunotherapy; SEK, Swedish Krona; SLIT, sublingual immunotherapy.
Figure 6 Mean total annual waiting time-related absenteeism.

Table 2 Summary of Mean Costs per Category for One-Year and Three-Year Cohorts

Table 3 Results Comparison: Base Case and Sensitivity Analyses

Data Sharing Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.